303 results match your criteria: "Centre d'evaluation et de traitement de la douleur[Affiliation]"
Front Pharmacol
September 2022
Service de Pharmacologie Médicale, Centres Addictovigilance et Pharmacovigilance, Centre d'Evaluation et de Traitement de la Douleur, Inserm, CHU Clermont-Ferrand, Neuro-Dol, Université Clermont Auvergne, Clermont-Ferrand, France.
Public health issues related to chronic pain management and the risks of opioid misuse and abuse remain a challenge for practitioners. Data on the prevalence of disorders related to the use of prescribed opioids in patients suffering from chronic pain remains rather patchy, in particular because of the absence of a gold standard for their clinical assessment. We estimated the prevalence of prescription opioid misuse (POM), using a specific and validated opioid misuse scale (POMI-5F scale), in adults with chronic non-cancer pain.
View Article and Find Full Text PDFCereb Cortex
March 2023
Central Integration of Pain (Neuropain Lab) - Lyon Neuroscience Research Center, INSERM U1028, CNRS, UMR5292, Université Claude Bernard, 69677 Bron cedex, France.
Activation of the spinothalamic system does not always result in a subjective pain perception. While the cerebral network processing nociception is relatively well known, the one underlying its transition to conscious pain remains poorly described. We used intracranial electroencephalography in epileptic patients to investigate whether the amplitudes and functional connectivity of posterior and anterior insulae (PI and AI) and amygdala differ according to the subjective reports to laser stimuli delivered at a constant intensity set at nociceptive threshold.
View Article and Find Full Text PDFBr J Anaesth
September 2022
Centre d'Evaluation et de Traitement de la Douleur, Hôpital Cochin, Université Paris Cité, INSERM U987, Paris, France; CETD and INSERM U987, Hôpital Ambroise Paré, Boulogne-Billancourt, France. Electronic address:
Given the often disappointing results of pharmacotherapy, many patients with chronic pain seek to modify their lifestyle. Some lifestyle factors, such as the consumption of alcohol, tobacco, cannabis, or psychostimulants, are deleterious in this context, whereas others, such as physical activity and a balanced diet, are considered beneficial, but these require substantial effort on the part of patients. In all cases, it is important to analyse lifestyle factors in patients with chronic pain, without stigmatisation, as the co-existence of pain and inappropriate behaviour can be seen as double jeopardy in patients with pain.
View Article and Find Full Text PDFMedicina (Kaunas)
June 2022
PRISMATICS Lab (Predictive Research in Spine/Neuromodulation Management and Thoracic Innovation/Cardiac Surgery), Poitiers University Hospital, F-86000 Poitiers, France.
Motor control, movement impairment, and postural control recovery targeted in rehabilitation could be affected by pain. The main objective of this comprehensive review is to provide a synthesis of the effect of experimental and chronic pain on postural control throughout the available literature. After presenting the neurophysiological pathways of pain, we demonstrated that pain, preferentially localized in the lower back or in the leg induced postural control alteration.
View Article and Find Full Text PDFJ Clin Med
May 2022
Service Douleur, Soins palliatifs et de Support et UIC22, Hôpital Laennec, CHU, 44093 Nantes, France.
Background: Deep brain stimulation (DBS) is an effective technique to treat patients with advanced Parkinson's disease. The surgical procedure of DBS implantation is generally performed under local anesthesia due to the need for intraoperative clinical testing. However, this procedure is long (5-7 h on average) and, therefore, the objective that the patient remains co-operative and tolerates the intervention well is a real challenge.
View Article and Find Full Text PDFJMIR Form Res
March 2022
Centre d'évaluation et de traitement de la douleur, Centre Hospitalier Universitaire de Clermont-Ferrand, Clermont-Ferrand, France.
Background: Chronic pain affects approximately 30% of the general population, severely degrades quality of life (especially in older adults) and professional life (inability or reduction in the ability to work and loss of employment), and leads to billions in additional health care costs. Moreover, available painkillers are old, with limited efficacy and can cause significant adverse effects. Thus, there is a need for innovation in the management of chronic pain.
View Article and Find Full Text PDFEur J Pain
April 2022
CHU Clermont-Ferrand, Plateforme d'Investigation Clinique/CIC Inserm 1405, Clermont-Ferrand, France.
Cereb Cortex
September 2022
Central Integration of Pain (NeuroPain) Lab-Lyon Neuroscience Research Center, INSERM U1028, CNRS, UMR5292, Université Claude Bernard, Bron 69677, France.
Pain Manag
May 2022
Inserm, U1172 - CHU Lille, Lille Neuroscience & Cognition, Centre of Excellence in Neurodegenerative Disease, Univ. Lille, Labex DISTAlz, F-59000, Lille, France.
Lower interoceptive abilities are a characteristic of chronic pain conditions. Social support plays an important role in chronic low back pain (cLBP) but social cognitive skills have rarely been investigated. This study aimed to characterize interoceptive and social cognitive abilities in cLBP and to study the relationship between both domains that have been brought closer together by brain predictive coding models.
View Article and Find Full Text PDFNeuropharmacology
March 2022
Centre National de la Recherche Scientifique, Université de Strasbourg, Institut des Neurosciences Cellulaires et Intégratives, Strasbourg, France. Electronic address:
Neuropathic pain arises as a consequence of a lesion or disease affecting the somatosensory nervous system. It is accompanied by neuronal and non-neuronal alterations, including alterations in intracellular second messenger pathways. Cellular levels of 3',5'-cyclic adenosine monophosphate (cAMP) and 3',5'-cyclic guanosine monophosphate (cGMP) are regulated by phosphodiesterase (PDE) enzymes.
View Article and Find Full Text PDFBull Cancer
May 2022
Centre d'évaluation et de traitement de la douleur, équipe mobile de soins de support & palliatifs, pôle cancérologie & spécialités médicales, Valenciennes, France. Electronic address:
Cancer pain remains a major public health issue. Despite progress in pain medicine thanks to the interest shown in early and timely supportive care, more than half the patients managed for cancer are in pain. One of the key factors in high quality multidisciplinary management throughout the care pathway is to assess more than just pain: it is necessary to assess the patient as a whole.
View Article and Find Full Text PDFNat Commun
November 2021
Aix-Marseille-Université, CNRS, Laboratoire de Neurosciences Cognitives, UMR 7291, CS8011, Bd Pierre Dramard, 13344, Marseille, France.
Acupunct Med
April 2022
Laboratory of Neuroscience, Hospital Sírio-Libanês, São Paulo, Brazil.
Background: Neuropathic pain (NP) is a complex disease that remains challenging to treat. Low-frequency dense-and-disperse (DD) electroacupuncture (EA) has been used as adjuvant therapy for neuropathic pain; however, its analgesic effect decreases as stimulation time increases, or when it is repeatedly used. We hypothesized that a new frequency parameter could improve the effectiveness of EA, and aimed to compare the efficacy and duration of the analgesic effect between classic DD-EA and non-repetitive and non-sequential frequency (random frequency (RF)-EA) in neuropathic rats.
View Article and Find Full Text PDFNeurosci Biobehav Rev
December 2021
Postgraduate Program in Neuroscience, Center of Biological Sciences, Federal University of Santa Catarina, Florianópolis, Santa Catarina, Brazil.
Fibromyalgia (FM) syndrome is a common illness characterized by chronic widespread pain, sleep problems, fatigue, and cognitive difficulties. Dysfunctional neurotransmitter systems that influence the body's endogenous stress response systems are thought to underlie many of the major FM-related symptoms. A model of FM pathogenesis suggests biological and psychosocial variables interact to influence the genetic predisposition, but the precise mechanisms remain unclear.
View Article and Find Full Text PDFNeurology
January 2022
From the Service de Génétique Moléculaire (F.R., C. Barbance, J.H., E.T.-L.), Hôpital Saint-Louis, Assistance Publique des Hôpitaux de Paris; INSERM UMR-S1141 (F.R., E.T.-L.), Université Paris; Emergency Headache Centre (C. Roos), Lariboisière Hospital, Paris; INM (A.R.), Univ Montpellier, INSERM, CHU Montpellier, Département de Neuropédiatrie; Service de Neurologie Pédiatrique (S.A.), Hôpital Robert Debré, Assistance Publique des Hôpitaux de Paris; Service de Neurologie et Pathologie du Mouvement (G.B.), CHRU de Lille; Pain Department (M.B., A. Donnet, S.R.), FHU INNOVPAIN, Hôpital La Timone, Marseille; Equipe Douleur et Soins Palliatifs Pédiatriques (C. Boulanger), Hôpital des Enfants, CHU Toulouse; Service de Neuropédiatrie (A.C.), Centre Hospitalier d'Arras; Service de Pédiatrie-Néonatologie du CH Remiremont (F.C.); Service de Neurologie Pédiatrique (E.C.), Hôpital des Enfants, CHU de Toulouse; Service de Neuropédiatrie (J.-C.C.), Hôpital Roger-Salengro, CHRU de Lille; Service de Neuropédiatrie (A. Defo), CH de Cayenne, Guyane; Department of Neurology (G.D.), Hospices Civils de Lyon; Lyon Neuroscience Research Center (CRNL) (G.D.), Brain Dynamics and Cognition Team (Dycog), INSERM U1028, CNRS UMR5292; Neurology Department (N. Gaillard, A. Ducros), Montpellier University Hospital; Department of Neurology (E.M.), Rouen University Hospital; Service de Neurologie (N. Guy), CHU Clermont-Ferrand; Service de Pédiatrie (S.L.), Centre Hospitalier d'Avignon; Service de Pédiatrie et Unité d'Urgence Pédiatrique (L.L.M.), Centre Hospitalier de Cornouaille, Quimper; Centre d'Evaluation et de Traitement de la Douleur dans le service de Neurochirurgie (C.L.), CHU de Lille; Service de Neurologie Centre Hospitalier de Narbonne (C.R.); Service de Neurologie Vasculaire (C. Rey), CHU Timone, Marseille; Centre de Génétique et Centre de Référence des Anomalies du Développement et Syndromes Malformatifs de l'Interrégion Est (C.T.), Centre Hospitalier Universitaire Dijon; Département de Neurologie (F.V.), Centre Hospitalier Intercommunal d'Aix-Pertuis, Aix-en-Provence; and Charles Coulomb Laboratory (A. Ducros), UMR 5221 CNRS-UM, Montpellier University, France.
Background And Objective: variants have been reported in a few cases of patients with hemiplegic migraine. To clarify the role of in familial hemiplegic migraine, we studied this gene in a large cohort of affected probands.
Methods: was analyzed in 860 probands with hemiplegic migraine, and variations were identified in 30 probands.
Clin Pract
September 2021
Pain in Motion Research Group (PAIN), Department of Physiotherapy, Human Physiology and Anatomy, Faculty of Physical Education & Physiotherapy, Vrije Universiteit Brussel, 1050 Brussel, Belgium.
The Central Sensitization Inventory (CSI) measurement properties in patients having nonspecific, noncancer pain are well-established. However, studies examining the reliability and validity of either the CSI or the Central Sensitization Inventory short-form version (CSI-9) in breast cancer survivors (BCS) are scarce. The purpose was to evaluate convergent validity and internal consistency of the CSI and CSI-9.
View Article and Find Full Text PDFJ Bodyw Mov Ther
July 2021
Postgraduate Program in Health Sciences, University of Southern Santa Catarina, Florianópolis, SC, Brazil. Electronic address:
Background: The aging process reduces adaptive balance responses. Two-thirds of older adults with cognitive problems suffer at least one fall every year, a rate three times higher than that observed in older adults without dementia. This cross-sectional study aims to analyze the relationship between balance and cognitive status in adults older than 50 years.
View Article and Find Full Text PDFRev Neurol (Paris)
September 2021
Centre d'evaluation et de traitement de la douleur, service de neurochirurgie, hôpital Salengro, CHU de Lille, 59037 Lille Cedex, France. Electronic address:
Around 15% to one-third of migraineurs experience aura. Aura is a fully reversible focal neurological phenomenon involving visual, sensory, speech, and/or motor symptoms that develops gradually and usually precedes the headache phase. The pivotal role of cortical spreading depression (CSD) as a mechanism underlying aura has been widely supported by a large body of studies.
View Article and Find Full Text PDFRev Neurol (Paris)
September 2021
Department of Neurology, Gui de Chauliac Hospital, CHU Montpellier, University of Montpellier, 34000 Montpellier, France.
The French Headache Society proposes updated French guidelines for the management of migraine. The first part of these recommendations is focused on the diagnosis and assessment of migraine. First, migraine needs to be precisely diagnosed according to the currently validated criteria of the International Classification of Headache Disorders, 3d version (ICHD-3).
View Article and Find Full Text PDFRev Neurol (Paris)
September 2021
Neurological hospital, Lyon, neuroscience research center (CRNL), INSERM U1028, CNRS UMR5292, Lyon, France. Electronic address:
The French Headache Society proposes updated French guidelines for the management of migraine. This article presents the second part of the guidelines, which is focused on the pharmacological treatment of migraine, including both the acute treatment of attacks and the prophylaxis of episodic migraine as well as chronic migraine with and without medication overuse. The specific situations that can be encountered in women with migraine are also discussed, including pregnancy, menstrual migraine, contraception and hormonal replacement therapy.
View Article and Find Full Text PDFRev Neurol (Paris)
September 2021
Department of Neurology, Gui-de-Chauliac Hospital, CHU de Montpellier, University of Montpellier, 34000 Montpellier, France.
The French Headache Society proposes updated French guidelines for the management of migraine. This article presents the third part of the guidelines, which is focused on the non-pharmacological treatment of migraine, including physical exercise, dietary supplements and plants, diets, neuromodulation therapies, acupuncture, behavioral interventions and mindfulness therapy, patent foramen ovale closure and surgical nerve decompression.
View Article and Find Full Text PDFRev Neurol (Paris)
September 2021
Centre d'Evaluation et de Traitement de la Douleur, Service de Neurochirurgie, hôpital Salengro, CHU de Lille, 2, avenue Oscar Lambret, 59037 Lille cedex, France. Electronic address:
Regular and frequent use of analgesics and acute antimigraine drugs can increase the frequency of headache, and induce the transition from episodic to chronic migraine or medication-overuse headache (MOH). The one-year prevalence of this condition is between 1% and 2% in Europe, provoking substantial burden. MOH is more prevalent in people with comorbid depression, anxiety, and other chronic pain conditions.
View Article and Find Full Text PDFEur J Pain
January 2022
Centre d'Evaluation et de Traitement de la Douleur, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
Background And Objective: Neuropathic pain arises as a direct consequence of a lesion or disease affecting the somatosensory system. A number of preclinical studies have provided evidence for the involvement of cytokines, predominantly secreted by a variety of immune cells and by glial cells from the nervous system, in neuropathic pain conditions. Clinical trials and the use of anti-cytokine drugs in different neuropathic aetiologies support the relevance of cytokines as treatment targets.
View Article and Find Full Text PDFTherapie
August 2022
Pôle 8 cancérologie et spécialités médicales, centre d'évaluation et de traitement de la douleur, centre hospitalier de Valenciennes, 59300 Valenciennes, France.
Neurology
July 2021
From the Department of Neurology (E.E.-K.), BG University Hospital Bergmannsheil GmbH, Ruhr-University Bochum, Germany; INSERM U-987 (N.A., D.B.), Centre D'Evaluation et de Traitement de La Douleur, CHU Ambroise Paré, Boulogne-Billancourt; Université Versailles-Saint-Quentin (N.A., D.B.), Versailles, France; Department of Anaesthesiology (R.F.), Critical Care Medicine, Pain Therapy & Palliative Care, Pain Center Lake Starnberg, Benedictus Hospital Feldafing; Department of Anaesthesiology (R.F.), Klinikum rechts der Isar, Technische Universität München, Munich; Division of Neurological Pain Research and Therapy (J.G., J.S., R.B.), Department of Neurology, Universitätsklinikum Schleswig-Holstein, Campus Kiel, Germany; Department of Pain Management and Research (P.H.), Norwegian National Advisory Unit on Neuropathic Pain, Division of Emergencies and Critical Care, Oslo University Hospital, Norway; Department of Molecular Medicine and Surgery (P.H.), Karolinska Institutet, Stockholm, Sweden; Pain Medicine (B.K., J.V.), Chelsea and Westminster Hospital NHS Foundation Trust; Pain Research (B.K.), Department Surgery and Cancer, Faculty of Medicine, Imperial College, Chelsea and Westminster Campus, London, UK; University Hospital of Pediatrics and Adolescent Medicine (C.M.), Ruhr-University Bochum, Germany; MS Medical Consulting (M.S.); Karolinska Institute (M.S.), Department of Physiology and Pharmacology, Stockholm, Sweden; Department of Neurology (T.T.), Klinikum rechts der Isar, Technische Universität München, Munich; Department of Neurophysiology (R.-D.T., J.V.), Mannheim Center for Translational Neuroscience MCTN, Medical Faculty Mannheim, Heidelberg University, Germany; Danish Pain Research Center (L.V.), Department of Clinical Medicine, and Department of Oncology (L.V.), Aarhus University Hospital, Denmark.
Objective: To test whether contralateral sensory abnormalities in the clinically unaffected area of patients with unilateral neuropathic pain are due to the neuropathy or pain mechanisms.
Methods: We analyzed the contralateral clinically unaffected side of patients with unilateral painful or painless neuropathy (peripheral nerve injury [PNI], postherpetic neuropathy [PHN], radiculopathy) by standardized quantitative sensory testing following a validated protocol. Primary outcome was the independent contribution of the following variables on the contralateral sensory function using generalized linear regression models: pain intensity, disease duration, etiology, body area, and sensory patterns in the most painful area.